Research / Clinical Trials
Our practice offers clinical trials which help determine whether newly developed treatments are safe and effective in treating Multiple Sclerosis. These studies are important research tools for the developing new treatment options for this chronic disease. Clinical trials also provide patients with access to new treatment options and new therapies that are not offered to the general population.
As new technologies and therapeutic options become available, Hope Neurology Multiple Sclerosis Center utilizes clinical trials to provide innovative treatment options to our patients.
Clinical research studies provide patients with new medications and access to comprehensive disease management. By working closely with our pharmaceutical sponsors, we strive to improve the health, hope and well-being of our patients.
For more information on any of our studies, please call 865. 218.6222 and ask to speak with Brenda, Geneva or Linsey or email us at firstname.lastname@example.org
Enrolling Clinical Trials:
Exchange Study: Clinical Trial Protocol Number CBAF312AUS02
Exploring the safety and tolerability of conversion from oral or injectable disease modifying therapies to dose-titrated Oral Siponimod in patients with advancing forms of relapsing remitting multiple sclerosis: A 6 month open label, multi-center Phase IIIb study.
Ongoing Clinical Trials